Neurological and vascular complications of primary and secondary brain tumours: EANO-ESMO Clinical Practice Guidelines for prophylaxis, diagnosis, treatment and follow-up.
Por:
Roth P, Pace A, Le Rhun E, Weller M, Ay C, Cohen-Jonathan Moyal E, Coomans M, Giusti R, Jordan K, Nishikawa R, Winkler F, Hong JT, Ruda R, Villà S, Taphoorn MJB, Wick W and Preusser M
Publicada:
1 feb 2021
Ahead of Print:
24 nov 2020
Resumen:
Filiaciones:
Roth P:
Department of Neurology and Brain Tumor Center, University Hospital and University of Zurich, Zurich, Switzerland
Pace A:
Neuroncology Unit, IRCCS Regina Elena Cancer Institute, Rome, Italy
Le Rhun E:
Department of Neurology and Brain Tumor Center, University Hospital and University of Zurich, Zurich, Switzerland
Université Lille, U-1192, Lille, France
Inserm, U-1192, Lille, France
Centre Hospitalier Universitaire CHU, Lille, General and Stereotaxic Neurosurgery Service, Lille, France
Oscar Lambret Center, Breast Cancer Department, Lille, France
Weller M:
Department of Neurology and Brain Tumor Center, University Hospital and University of Zurich, Zurich, Switzerland
Ay C:
Division of Haematology and Haemostaseology, Department of Medicine I, Comprehensive Cancer Center Vienna, Vienna, Austria
Cohen-Jonathan Moyal E:
Radiation Oncology Department, Institut Claudius Regaud, Université Paul Sabatier, Toulouse, France
Institut Universitaire du Cancer de Toulouse IUCT Oncopole, Toulouse, France
Coomans M:
Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands
Giusti R:
Medical Oncology Unit, Azienda Ospedaliero Universitaria Sant'Andrea, Rome, Italy
Jordan K:
Department of Medicine V, Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany
Nishikawa R:
Department of Neuro-Oncology/Neurosurgery, Saitama Medical University International Medical Center, Saitama, Japan
Winkler F:
Department of Neurology and Neurooncology Program, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany
Clinical Cooperation Unit Neurooncology, German Cancer Research Center (DKFZ), Heidelberg, Germany
German Cancer Consortium (DKTK), Heidelberg, Germany
Hong JT:
Department of Neurosurgery, Eunpyeong St. Mary's Hospital, Seoul, The Catholic University of Korea, Republic of Korea
Ruda R:
Department of Neuro-Oncology, City of Health and Science and University of Turin, Turin, Italy
:
Catalan Institute of Oncology, HU Germans Trias, Badalona, Universitat Autònoma de Barcelona, Barcelona, Spain
Taphoorn MJB:
Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands
Department of Neurology, Haaglanden Medical Center, The Hague, The Netherlands
Wick W:
Department of Neurology and Neurooncology Program, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany
Preusser M:
Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria
|